Literature DB >> 8954936

Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1).

R Kekuda1, P D Prasad, Y J Fei, F H Leibach, V Ganapathy.   

Abstract

We have isolated a cDNA clone from a human placental choriocarcinoma cell (JAR) cDNA library which codes for a functional type 1 sigma receptor. An RT-PCR product obtained from guinea pig kidney mRNA using primers specific for the guinea pig sigma receptor cDNA was used to screen the cDNA library. The hSigmaR1 cDNA predicts a protein of 223 amino acids with a single putative transmembrane domain. The amino acid sequence exhibits 93% identity with the guinea pig sigma receptor. When functionally expressed in HeLa cells, the hSigmaR1 cDNA enhances the binding of [3H]-haloperidol, a sigma receptor ligand, to the HeLa cell membranes. The inhibitor specificity of the cloned hSigmaR1 indicates that it is the type 1 sigma receptor. Several human tissues, including placenta, liver, and brain, and several human cell lines express the SigmaR1 mRNA (1.7 kb) to a variable extent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954936     DOI: 10.1006/bbrc.1996.1842

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  96 in total

1.  Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem.

Authors:  M P Morin-Surun; T Collin; M Denavit-Saubié; E E Baulieu; F P Monnet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP.

Authors:  P J Lupardus; R A Wilke; E Aydar; C P Palmer; Y Chen; A E Ruoho; M B Jackson
Journal:  J Physiol       Date:  2000-08-01       Impact factor: 5.182

3.  Transcriptomic classification of antitumor agents: application to the analysis of the antitumoral effect of SR31747A.

Authors:  Jean-Bernard Ferrini; Omar Jbilo; Annick Peleraux; Therese Combes; Hubert Vidal; Sylvaine Galiegue; Pierre Casellas
Journal:  Gene Expr       Date:  2003

Review 4.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

Review 5.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

6.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Authors:  Tsung-Ping Su; Teruo Hayashi; Tangui Maurice; Shilpa Buch; Arnold E Ruoho
Journal:  Trends Pharmacol Sci       Date:  2010-10-01       Impact factor: 14.819

7.  Molecular imaging of σ receptors: synthesis and evaluation of the potent σ1 selective radioligand [18F]fluspidine.

Authors:  Steffen Fischer; Christian Wiese; Eva Grosse Maestrup; Achim Hiller; Winnie Deuther-Conrad; Matthias Scheunemann; Dirk Schepmann; Jörg Steinbach; Bernhard Wünsch; Peter Brust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-12       Impact factor: 9.236

Review 8.  The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines.

Authors:  Arnold E Ruoho; Uyen B Chu; Subramaniam Ramachandran; Dominique Fontanilla; Timur Mavlyutov; Abdol R Hajipour
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

9.  Photoaffinity labeling of the sigma-1 receptor with N-[3-(4-nitrophenyl)propyl]-N-dodecylamine: evidence of receptor dimers.

Authors:  Uyen B Chu; Subramaniam Ramachandran; Abdol R Hajipour; Arnold E Ruoho
Journal:  Biochemistry       Date:  2013-01-28       Impact factor: 3.162

Review 10.  Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.